UCB invites you to join a conversation on…

Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis with the First and Only Approved IL-17A and IL-17F Inhibitor

Presented by Jeffrey Crowley, MD.

Please contact Jennifer Price at jennifer.price@ucb.com or by calling 503-619-7941 to RSVP!

More information can be found on the event flyer.